A. Albeck et al., TELLURIUM COMPOUNDS - SELECTIVE-INHIBITION OF CYSTEINE PROTEASES AND MODEL REACTION WITH THIOLS, Inorganic chemistry, 37(8), 1998, pp. 1704-1712
Ammonium trichloro(dioxoethylene-O,O')tellurate (AS101) is an organote
llurium(IV) compound that exhibits immunomodulation activity. In light
of the unique Te(IV)-thiol chemistry, it was tested asa selective cys
teine protease inhibitor. Although no inhibitory activity of serine-,
metallo-. or aspartic proteases was observed, AS101 exhibited time-and
concentration-dependent inactivation of cysteine proteases. The kinet
ic parameters of inactivation of papain were K-i = 3.5 +/- 2.0 mu M an
d k(i) = (5.1 +/- 0.4) x 10(-2) min(-1). The enzymatic activity could
be recovered by treatment with thiols, indicating that the inactivatio
n involves oxidation of the active-site thiol to a disulfide bond (Enz
-S-S-R) or to a species containing a Te-S bond such as Enz-S-Te-S-R. G
el permeation chromatography established that the R group is a small m
olecule and excludes the possibility of dimerization of the enzyme its
elf. It was further established that some other Te(IV) derivatives cou
ld also inactivate cysteine proteases, while Te(VI) derivatives did no
t exhibit any such inhibitory activity. In order to understand the che
mistry underlying the cysteine protease inactivation by AS101 and othe
r organotellurium(IV) compounds, their interaction with the model comp
ound cysteine was studied. While the Te(VI) derivatives did not intera
ct with cysteine, all of the Te(IV) compounds interacted with 4 equiv
of cysteine. The kinetics of this interaction is first order in Te and
second order in thiol, yielding a third-order rate constant of simila
r to 10(6) M-2 s(-1), as determined for the interaction between AS101
with cysteine. The interactions between Te derivatives and cysteine in
DMSO were followed by Te-125 and C-13 NMR. While Te(VI) compounds did
not undergo any changes upon interaction with cysteine. on the basis
of their Te-125 NMR, the Te(IV) derivatives interacted with 4 equiv of
cysteine, yielding new stable Te(IV) compounds. These compounds were
tentatively designated as Te(cysteine)4 or its high-valence complex wi
th other components in the reaction mixture. These results expand our
understanding of tellurium chemistry and correlate well with its biolo
gical activity. Such knowledge can be applied for the development of n
ovel biologically active tellurium compounds.